Works matching IS 21938210 AND DT 2024 AND VI 14 AND IP 9
Results: 22
Efficacy of a Multi-lamellar Emulsion Containing a Synthetic Sphingosine Kinase 1 Activator and Pseudoceramide in Patients with Atopic Dermatitis: A Randomized Controlled Trial.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2591, doi. 10.1007/s13555-024-01254-5
- By:
- Publication type:
- Article
Extended Half-life Antibodies: A Narrative Review of a New Approach in the Management of Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2393, doi. 10.1007/s13555-024-01253-6
- By:
- Publication type:
- Article
A 3-Year Experience with Tildrakizumab Treatment for Patients with Plaque Psoriasis in Clinical Practice.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2645, doi. 10.1007/s13555-024-01252-7
- By:
- Publication type:
- Article
Restoration of the Ultrastructural Integrity of the Dermal Collagen Network by 12-Week Ingestion of Special Collagen Peptides.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2509, doi. 10.1007/s13555-024-01251-8
- By:
- Publication type:
- Article
Direct and Indirect Effect of Guselkumab on Anxiety, Depression, and Quality of Life in Patients with Moderate-to-Severe Plaque Psoriasis: A Mediation Analysis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2577, doi. 10.1007/s13555-024-01250-9
- By:
- Publication type:
- Article
A Review of Hidradenitis Suppurativa in Special Populations: Considerations in Children, Pregnant and Breastfeeding Women, and the Elderly.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2407, doi. 10.1007/s13555-024-01249-2
- By:
- Publication type:
- Article
Prospective Clinical Study: Full-Body Blue Irradiation in the Treatment of Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2631, doi. 10.1007/s13555-024-01248-3
- By:
- Publication type:
- Article
Consensus Recommendations for the Management of Atopic Dermatitis in the United Arab Emirates.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2299, doi. 10.1007/s13555-024-01247-4
- By:
- Publication type:
- Article
Management of Moderate-to-Severe Atopic Dermatitis in Adults: A Cross-Sectional Survey of Dermatologists Within the Asia–Pacific Region.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2559, doi. 10.1007/s13555-024-01246-5
- By:
- Publication type:
- Article
Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2539, doi. 10.1007/s13555-024-01245-6
- By:
- Publication type:
- Article
Quality of Life and Burden of Moderate-to-Severe Atopic Dermatitis in Adult Patients Within the Asia–Pacific Region: A Cross-sectional Survey.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2479, doi. 10.1007/s13555-024-01244-7
- By:
- Publication type:
- Article
Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2653, doi. 10.1007/s13555-024-01243-8
- By:
- Publication type:
- Article
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2621, doi. 10.1007/s13555-024-01242-9
- By:
- Publication type:
- Article
Assessing Participants' Experiences with Vitiligo from Patient Interviews.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2467, doi. 10.1007/s13555-024-01241-w
- By:
- Publication type:
- Article
Efficacy of Upadacitinib and Dupilumab on Achieving Stringent and Composite Skin and Itch Outcomes: an Indirect Comparison of Adults with Moderate-to-Severe Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2457, doi. 10.1007/s13555-024-01240-x
- By:
- Publication type:
- Article
Highlights of Gene and Cell Therapy for Epidermolysis Bullosa and Ichthyosis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2379, doi. 10.1007/s13555-024-01239-4
- By:
- Publication type:
- Article
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2523, doi. 10.1007/s13555-024-01238-5
- By:
- Publication type:
- Article
Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2495, doi. 10.1007/s13555-024-01237-6
- By:
- Publication type:
- Article
An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2443, doi. 10.1007/s13555-024-01236-7
- By:
- Publication type:
- Article
Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2427, doi. 10.1007/s13555-024-01231-y
- By:
- Publication type:
- Article
Current Treatments for Generalized Pustular Psoriasis: A Narrative Summary of a Systematic Literature Search.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2331, doi. 10.1007/s13555-024-01230-z
- By:
- Publication type:
- Article
Comparison of Drug-Free Remission after the End of Phase III Trials of Three Different Anti-IL-23 Inhibitors in Psoriasis.
- Published in:
- Dermatology & Therapy, 2024, v. 14, n. 9, p. 2607, doi. 10.1007/s13555-024-01229-6
- By:
- Publication type:
- Article